Photoselective green-light laser vaporisation vs. TURP for BPH: Meta-analysis

Asian Journal of Andrology

Volumn 14, Issue 5, 2012, Pages 720-725

  Ding, Hui ^a   Du, Wan ^a   Lu, Ze Ping ^a   Zhai, Zhen Xing ^a   Wang, Han Zhang ^b   Wang, Zhi Ping ^a  

^a LANZHOU UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

benign prostatic hyperplasia (BPH); meta analysis; photoselective vaporisation; transurethral resection of the prostate (TURP)

Indexed keywords

ARTICLE; BLADDER OBSTRUCTION; CATHETER REMOVAL; COCHRANE LIBRARY; DATA EXTRACTION; DYSURIA; ELECTROSURGERY; EMBASE; FOLLOW UP; HUMAN; INCIDENCE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LENGTH OF STAY; MEDLINE; META ANALYSIS; OPERATION DURATION; ORGAN SIZE; PERFORATION; PHOTOSELECTIVE GREEN LIGHT LASER VAPORISATION OF THE PROSTATE; POSTVOID RESIDUAL URINE VOLUME; PROSTATE; PROSTATE HYPERTROPHY; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROGRADE EJACULATION; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION;

HUMANS; LASER THERAPY; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84866251377     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.56     Document Type: Article

References (39)

1. Berry SJ Coffey DS Walsh PC Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9.
2. Abrams P Cardozo L Fall M Griffiths D Rosier P et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
3. Speakman MJ. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): more than treating symptoms? Eur Urol Suppl 2008; 7: 680-9.
4. Stovsky MD Griffiths RI Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006; 176: 1500-6.
5. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006; 49: 961-9.
6. Te A. Current state of the art photoselective vaporization prostatectomy: Laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2007; 10: S2-5.
7. Oesterling JE. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. N Engl J Med 1995; 332: 99-109.
8. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol2003; 170: 530-47.
9. Bouchier-Hayes DM Anderson P van Appledorn S Bugeja P Costello AJ. KTP laser versus transurethral resection: Early results of a randomized trial. J Endourol 2006; 20: 580-5.
10. Al-Ansari A Younes N Sampige VP Al-Rumaihi K Ghafouri A et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. Eur Urol 2010; 58: 349-55.
11. Bouchier-Hayes DM van Appledorn S Bugeja P Crowe H Challacombe B et al. A Randomized Trial Of Photoselective Vaporization Of The Prostate Using The 80-W Potassium-titanyl-phosphate Laser Vs Transurethral Prostatectomy With A 1-year Follow-up. BJU Int 2010; 105: 964-9.
12. Capitan C Blazquez C Martin MD Hernandez V de la Pena E et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia Randomized Clinical Trial With 2-year Follow-up. Eur Urol 2011; 60 734-9.
13. Choi B Tabatabaei S Bachmann A Collins E de la Rosette J et al. GreenLight HPS 120-W laser for benign prostatic hyperplasia: Comparative complications and technical recommendations. Eur Urol Suppl 2008; 7: 384-92.
14. Heinrich E Wendt-Nordahl G Honeck P Alken P Knoll T et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: Comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 2010; 24: 75-9.
15. Kirby RS. GreenLight photoselective vaporization of the prostate. Prostate Cancer Prostatic Dis 2007; 10: S1.
16. Stafinski T Menon D Harris K Gray G Gian J. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Can Urol Assoc J 2008; 2: 124-34.
17. Higgins J Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. Updated September 2009. Oxford: The Cochrane Collaboration; 2009.
18. Wells GA Shea B O'Connell D Peterson J Welch V et al. The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009. Available from: http://www.ohri.ca/programs/clinical- epidemiology/oxford.htm [cited 2009 Oct 19].
19. Shingleton WB Terrell F Renfroe DL Kolski JM Fowler JE Jr. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999; 54: 1017-21.
20. Shingleton WB Farabaugh P May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002; 60: 305-8.
21. Bachmann A Schurch L Ruszat R Wyler SF Seifert HH et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP) Prospective Bi-centre Study Of Perioperative Morbidity Early Functional Outcome Prospective Bi-centre Study Of Perioperative Morbidity Early Functional Outcome. Eur Urol 2005; 48 965-71.
22. Horasanli K Silay MS Altay B Tanriverdi O Sarica K et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: A short-term prospective randomized trial. Urology 2008; 71: 247-51.
23. Ruszat R Wyler SF Seitz M Lehmann K Abe C et al. Comparison of potassiumtitanyl- phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008; 102: 1432-8.
24. Tugcu V Tasci AI Sahin S Zorluoglu F. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: A prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 1519-25.
25. Nomura H Seki N Yamaguchi A Naito S. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia. Int J Urol 2009; 16: 657-62.
26. Tasci AI Tugcu V Sahin S Zorluoglu F. Rapid communication: Photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: A prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008; 22: 347-53.
27. Pereira-Correia JA de Moraes Sousa KD Santos JB de Morais Perpetuo D Lopes-da- Silva LF et al. GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (,60 mL): A 2-year randomized double-blind prospective urodynamic investigation. BJU Int; e-pub ahead of print 18 Jan 2012; doi:10.1111/j.1464- 410X.2011.10878.x.
28. Chen J Wang M Wang S Sun P Zhao Y et al. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: A prospective nonrandomized two-center trial. Urology 2012; 79: 650-4.
29. Burke N Whelan JP Goeree L Hopkins RB Campbell K et al. Safety and efficacy of transurethral resection of prostate glands up to 150 ml: A prospective comparative study with 1 year of followup. J Urol 2004; 172: 611-5.
30. Borboroglu PG Kane CJ Ward JF Roberts JL Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 162: 1307- 10.
31. Muzzonigro G Milanese G Minardi D Yehia M Galosi AB et al. Safety and efficacy of transurethral resection of prostate glands up to 150 ml: A prospective comparative study with 1 year of followup. J Urol 2004; 172: 611-5.
32. Hahn RG. Smoking increases the risk of large scale fluid absorption duringtransurethral prostatic resection. J Urol 2001; 166: 162-5.
33. Frieben RW Lin HC Hinh PP Berardinelli F Canfield SE et al. The impact ofminimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: A systematic review. Asian J Androl 2010; 12: 500-8.
34. Bouchier-Hayes DM. Photoselective vaporization of the prostate - towards a new standard. Prostate Cancer Prostatic Dise 2007; 10: S10-4.
35. Secretariat Medical Advisory. Energy Delivery Systems for Treatment of Benign Prostatic Hyperplasia. Toronto (ON): Ontario Ministry of Health and Long Term Care; 2006.
36. Goh AC Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: A cost analysis. J Urol 2010; 183: 1469-73.
37. Malek RS Kuntzman RS Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000; 163: 1730-3.
38. Malek RS Kuntzman RS Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005; 174: 1344-8.
39. Malek RS Kang HW Peng YS Stinson D Beck MT et al. Photoselective vaporization prostatectomy: Experience with a novel 180W532nmlithium triborate laser and fiber delivery system in living dogs. J Urol 2011; 185: 712-8.